GlaxoSmithKline to shed 380 jobs as Harlow research unit closes

GlaxoSmithKline will shed around 380 jobs as one of its research units in Essex closes.

The pharmaceutical giant will make one-third of the workforce redundant after projects for pain relief, anxiety and depression drugs end at GlaxoSmithKline in Harlow, the BBC reports.

The company said the plant was to remain open.

Sign up to our weekly round-up of HR news and guidance

Receive the Personnel Today Direct e-newsletter every Wednesday

Email(Required)

OptOut

From time to time, we will send you emails about selected products, events and services from Personnel Today and OHW+ - but you can choose to opt-out at any time. If you do not wish to receive these emails, please tick this box.

Comments

This field is for validation purposes and should be left unchanged.

Δ

A consultation period was under way but no new research projects would be started, a spokeswoman said.

The firm also said it would continue restructuring to bring in £500m of savings by 2012 but would “try to preserve jobs” wherever possible.